Home › B-Cell Lymphoma
Pag-aaral pangklinika para sa B-Cell Lymphoma na nagre-recruit sa U.S.
68 pag-aaral para sa B-Cell Lymphoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY17 pag-aaral
- Houston, TX16 pag-aaral
- Chicago, IL13 pag-aaral
- Nashville, TN12 pag-aaral
- Philadelphia, PA11 pag-aaral
- Rochester, MN10 pag-aaral
- Milwaukee, WI10 pag-aaral
- Boston, MA10 pag-aaral
- Baldwin Park, CA9 pag-aaral
- Cleveland, OH8 pag-aaral
- Salt Lake City, UT8 pag-aaral
- Seattle, WA8 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Columbus, OH7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Atlanta, GA7 pag-aaral
- Aurora, CO7 pag-aaral
- Washington, DC7 pag-aaral
- Dallas, TX7 pag-aaral
- Denver, CO7 pag-aaral
- Charlotte, NC6 pag-aaral
- San Antonio, TX6 pag-aaral
- Edison, NJ6 pag-aaral
- New Haven, CT6 pag-aaral
- Cincinnati, OH6 pag-aaral
- Mountain View, CA6 pag-aaral
- Portland, OR5 pag-aaral
- Ann Arbor, MI5 pag-aaral
- Richmond, VA5 pag-aaral
- Winston-Salem, NC5 pag-aaral
- St. Louis, MO5 pag-aaral
- Omaha, NE5 pag-aaral
- Kansas City, MO5 pag-aaral
- Jacksonville, FL4 pag-aaral
- Tampa, FL4 pag-aaral
- Miami, FL4 pag-aaral
- Louisville, KY4 pag-aaral
- Irvine, CA4 pag-aaral
- Cedar Rapids, IA4 pag-aaral
- Indianapolis, IN4 pag-aaral
Ayos sa estado
- Arizona5 pag-aaral
- California22 pag-aaral
- Colorado12 pag-aaral
- Connecticut6 pag-aaral
- District of Columbia3 pag-aaral
- Florida15 pag-aaral
- Georgia9 pag-aaral
- Illinois13 pag-aaral
- Indiana5 pag-aaral
- Iowa6 pag-aaral
- Kansas10 pag-aaral
- Kentucky4 pag-aaral
- Maryland7 pag-aaral
- Massachusetts10 pag-aaral
- Michigan8 pag-aaral
- Minnesota12 pag-aaral
- Missouri5 pag-aaral
- Nebraska5 pag-aaral
- New Jersey10 pag-aaral
- New York19 pag-aaral
- North Carolina10 pag-aaral
- Ohio17 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania16 pag-aaral
- Tennessee14 pag-aaral
- Texas26 pag-aaral
- Utah8 pag-aaral
- Virginia8 pag-aaral
- Washington11 pag-aaral
- Wisconsin11 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Nagre-recruitPhase 1
Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06173518A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05773040Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05272384BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT05370430A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07735533A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07101328A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07188558Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07283679A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06213311Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07520006A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07123454A Study of ARC-02 in B-cell NHL
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07691606Family Study of Lymphoproliferative Disorders
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT00626496A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06742996Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06131801A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06564038CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Nagre-recruitPhase 1/2
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT05442515GLORY: Glofit-GemOx With Liso-Cel For Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07711483Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Nagre-recruitPhase 2
Edad 60 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT06052826Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07097363Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07532525A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06528301Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06526793Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT05940272CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06026319Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.